Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1UC6
|
||||
| Drug Name |
4-{(R)-4-[Benzo[1,3]dioxol-5-ylmethyl-(4-methoxy-benzenesulfonyl)-amino]-4-hydroxycarbamoyl-butyryl}-piperazine-1-carboxylic acid ethyl ester
|
||||
| Synonyms |
CHEMBL80486
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H34N4O10S
|
||||
| Canonical SMILES |
CCOC(=O)N1CCN(CC1)C(=O)CC[C@@H](N(Cc2ccc3OCOc3c2)S(=O)(=O)c4ccc(OC)cc4)C(=O)NO
|
||||
| InChI |
InChI=1S/C27H34N4O10S/c1-3-39-27(34)30-14-12-29(13-15-30)25(32)11-9-22(26(33)28-35)31(17-19-4-10-23-24(16-19)41-18-40-23)42(36,37)21-7-5-20(38-2)6-8-21/h4-8,10,16,22,35H,3,9,11-15,17-18H2,1-2H3,(H,28,33)/t22-/m1/s1
|
||||
| InChIKey |
XHLWYEWXYHRDQW-JOCHJYFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Interstitial collagenase | Target Info | [1587926] | ||
| Neutrophil collagenase | Target Info | [1587926] | |||
| WikiPathways | TGF beta Signaling Pathway | ||||
| Bladder Cancer | |||||
| Activation of Matrix Metalloproteinases | |||||
| Degradation of collagen | |||||
| Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
| Oncostatin M Signaling Pathway | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Cell surface interactions at the vascular wall | |||||
| Matrix MetalloproteinasesWP2769:Activation of Matrix Metalloproteinases | |||||
| Matrix Metalloproteinases | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.